Japan's Nikkei Reverses Course, Ends Higher as Autos Rise
Japan's Nikkei Reverses Course, Ends Higher as Autos Rise; China Stocks Edge Down
Despite the absence of Overseas investors, a solid development is underway.
The Nikkei Average rebounded, finishing at 39,130.43 yen, up by 93.58 yen (with an estimated Volume of 1.7 billion 60 million shares). Buoyed by the previous day's rise in U.S. tech stocks, buying began early, pushing the Nikkei Average up to 39,180.59 yen shortly after the open. However, with European and American investors entering the Christmas holiday, market participation was low, leading to a shift to a negative trend due to position adjustments, with the index dropping to 38,927.16 yen during the middle of the morning session. The afternoon session saw a market environment characterized by strong stagnation.
The Nikkei average rebounded as trading became sparse with the Christmas holidays approaching.
On the 24th, the US Stocks market continued to rise. The Dow Inc average increased by 390.08 points to 43,297.03, while the Nasdaq finished trading up 266.25 points at 20,031.13. There was caution over rising long-term interest rates, leading to mixed results after the opening. With a shortened trading session on the day before the Christmas holiday, technology stocks continued to be bought, boosting the stock market. Anticipation of a Christmas rally from the 24th through the end of the year aided this rise, and as the day progressed, the gains were expanded at the close. Following the rise in US stocks,
Kuoal HD --- The pharmaceutical business is further expanding. The performance has significantly jumped with the subsidiary status of Daiichi Sankyo Esfa.
QOL Holdings <3034> is one of the major pharmacy chains, ranking second in the number of pharmacy stores and third in revenue (based on publicly traded companies). In addition to dispensing, it is also engaged in CSO*1 businesses, healthcare staffing and recruitment services, and pharmaceuticals. In October 2023, QOL acquired a 30% stake in Daiichi Sankyo Esfa Co., Ltd., which primarily develops authorized generic products (hereinafter referred to as AG products*2), making it an equity-method affiliate, and plans to proceed with further developments in April 2024.
G-tect has strengthened its advantages as a Honda-related Components manufacturer.
Fourth consecutive days of gain. Although a specialized manufacturer of body Components for Honda cars, Honda <7267> and Nissan <7201> announced discussions aimed at management integration on the 23rd, it is seen that Honda's leadership is expected to increase the competitive advantage for Components manufacturers. The stock price rebounded from the 13-week moving average as support, breaking through the 26-week line, and the 52-week line is now within reach.
